Header image

Concurrent Session 7C: Low dead-space needle and syringe scale-up and peer-led harm reduction: building prevention synergies in low- and middle-income countries

Tracks
Track 3
Friday, October 9, 2026
2:00 PM - 3:30 PM
Tycho + Kepler

Details

Global hepatitis C elimination strategies emphasise the need for community-centred and peer-led approaches to implementation. Yet, research on innovative harm reduction technologies and service designs for people who inject drugs often focus on whether they are ‘effective’, rather than how they are made to work in practice, and how they may be adapted to enhance their potential. This session is grounded in implementation experiences from community-led, multi-country research to increase the uptake and use of low dead-space needles and syringes (LDSS) in low- and middle-income countries. The critical role of community-led research and peer-led knowledge mobilisation in supporting implementation and uptake of new harm reduction technologies in diverse contexts will be explored. Audience members will be invited to reflect on country case studies, implementation tools, and broader perspectives from a diverse panel of experts and implementer and consider the implications for designing and implementing meaningful, community-responsive approaches that take advantage of prevention innovations across LMIC settings and beyond.


Speaker

Agenda Item Image
Dr Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)

Welcome

2:00 PM - 2:02 PM

Biography

Agenda Item Image
Mr Mat Southwell
Managing And Technical Director
Coact Technical Support LTD

Welcome

2:00 PM - 2:02 PM

Biography

Dr Sophia Schroeder
Senior Research Officer
Burnet Institute

Enhancing the harm reduction potential of low-deadspace injecting equipment research in low- and middle-income countries

2:02 PM - 2:10 PM

Biography

Agenda Item Image
Mr. Aniedi Akpan
Executive Director
Drug Free And Prevention Healthcare Organisation (DAPHO)

Community-led values and preferences research for expanding uptake and use of LDSS: Nigeria

2:10 PM - 2:18 PM

Biography

Angela McBride
Cab Member
HepC3P Global Community Advisory Board (CAB)

Community-led values and preferences research for expanding uptake and use of LDSS: South Africa

2:18 PM - 2:26 PM

Biography

Zhenya Mayilyan
Chairwoman
Real World Real People Ngo

Community-led values and preferences research for expanding uptake and use of LDSS: Armenia

2:26 PM - 2:35 PM

Biography

Mr Petik Yedigaryan
Autich
Real World Real People

Community-led values and preferences research for expanding uptake and use of LDSS: Armenia

2:26 PM - 2:35 PM

Biography

Agenda Item Image
Mr. Aniedi Akpan
Executive Director
Drug Free And Prevention Healthcare Organisation (DAPHO)

Panel Discussion

2:45 PM - 3:25 PM

Biography

Agenda Item Image
Prof Magdalena Harris
Professor Of Inclusion Health Sociology
London School Of Hygiene & Tropical Medicine

Panel Discussion

2:45 PM - 3:25 PM

Biography

Zhenya Mayilyan
Chairwoman
Real World Real People Ngo

Panel Discussion

2:45 PM - 3:25 PM

Biography

Angela McBride
Cab Member
HepC3P Global Community Advisory Board (CAB)

Panel Discussion

2:45 PM - 3:25 PM

Biography

Agenda Item Image
Mr Andrew Preston
Founder/Managing director
Exchange Supplies

Panel Discussion

2:45 PM - 3:25 PM

Biography

Dr Sophia Schroeder
Senior Research Officer
Burnet Institute

Panel Discussion

2:45 PM - 3:25 PM

Biography

Mr Petik Yedigaryan
Autich
Real World Real People

Panel Discussion

2:45 PM - 3:25 PM

Biography

Agenda Item Image
Dr Annie Madden
Project Lead
International Network of People Who Use Drugs (INPUD)

Where to from here?

3:25 PM - 3:30 PM

Biography

Agenda Item Image
Mr Mat Southwell
Managing And Technical Director
Coact Technical Support LTD

Where to from here?

3:25 PM - 3:30 PM

Biography

loading